Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter...
Hence then, the article about circulation publishes 6 month outcomes from first in human vcas trial of fieldforce pulsed field ablation system 82 freedom from vt vf recurrence and 98 reduction in burden was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden )
Also on site :
- Fakeeh Care Group reports FY 2025 revenue of SR3.1 billion, up 11% year on year; Attributable net profit reaches SR290 million, up 1% year on year or 14% excluding DSFH Madinah Ramp-Up Impact
- Gartner® reconoce a OpenWay Group en la Guía de Mercado 2026 de Plataformas de Pago de Comercio Digital
- Squirro Appoints David Clarke as Chief Executive Officer and Dr. Dorian Selz as Executive Deputy Chairman